In a LPS-induced mouse model of mastitis, geniposide (2.5, 5, and 10 mg/kg in vivo; 25, 50, and 100 μg/mL in vitro) has been demonstrated to alleviate inflammatory response by the inhibition of TLR4. Here, TLR4 is linked to mastitis.